Jul. 28 at 8:37 AM
$HR heads into its most important update of the quarter. Healthcare Realty will report Q2 results after the close on July 30, 2026, with the earnings call scheduled for July 31. Expectations matter because management raised 2026 normalized FFO guidance on April 30 to
$1.59-
$1.65 per share and lifted same-store cash NOI growth guidance to 3.75%-4.75%.
I will be watching occupancy, leasing spreads and leverage rather than the GAAP headline alone. In Q1, HR repurchased
$100 million of stock at an average
$17.38 while reporting net debt to adjusted EBITDA of 5.5x. The key question is whether operating improvement can continue without weakening the balance sheet.
$DOC remains a useful public-market comparison for medical real estate sentiment.
Not financial advice. Do your own research.
